ArticleJournal of surgical case reports2026
Surgical resection of a primary cardiac angiosarcoma and reconstruction of involved right atrium.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac angiosarcoma is an extremely rare malignant neoplasm, typically showing terrible prognosis, the gold standard treatment is surgical resection. We present a case of a 41-year-old woman who was diagnosed with a large right atrium, presenting with complaints of chest pain and shortness of breath for 2 weeks. Multimodality imaging results suggest a cardiac angiosarcoma. The patient underwent successful radical resection and single-stage reconstruction of the right atrium and superior vena cava under normothermic cardiopulmonary bypass with a beating heart. Histopathology confirmed the diagnosis of primary cardiac angiosarcoma. Based on the genetic results, tiragolumab was used for postoperative immunotherapy. Fortunately, no evidence of recurrence of angiosarcoma was showed 4 year after surgery. Radical surgical resection with reconstruction of the resected heart structures was the only possible salvage option for giant angiosarcoma, which led to hemodynamic instability. Followed by chemotherapy, this radical approach may prolong survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.